A
Amy S. Gargis
Researcher at Centers for Disease Control and Prevention
Publications - 28
Citations - 790
Amy S. Gargis is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Medicine & Plasmid. The author has an hindex of 7, co-authored 20 publications receiving 681 citations. Previous affiliations of Amy S. Gargis include Oak Ridge Institute for Science and Education & University of Alabama.
Papers
More filters
Journal ArticleDOI
Assuring the quality of next-generation sequencing in clinical laboratory practice
Amy S. Gargis,Lisa V. Kalman,Meredith W Berry,David P. Bick,David Dimmock,Tina Hambuch,Fei Lu,Elaine Lyon,Karl V. Voelkerding,Barbara A. Zehnbauer,Richa Agarwala,Sarah F. Bennett,Bin Chen,Ephrem L H Chin,John G. Compton,Soma Das,Daniel H. Farkas,Matthew J. Ferber,Birgit Funke,Manohar R. Furtado,Lilia Ganova-Raeva,Ute Geigenmüller,Sandra J Gunselman,Madhuri Hegde,Philip L. F. Johnson,Andrew Kasarskis,Shashikant Kulkarni,Thomas Lenk,CS Jonathan Liu,Megan Manion,Teri A. Manolio,Elaine R. Mardis,Jason D. Merker,Mangalathu S. Rajeevan,Martin G. Reese,Heidi L. Rehm,Birgitte B. Simen,Joanne M. Yeakley,Justin M. Zook,Ira M. Lubin +39 more
TL;DR: This research highlights the need to understand more fully the role of Epstein-Barr virus in infectious disease and its role in Hunter-LaSalle syndrome.
Journal ArticleDOI
Good laboratory practice for clinical next-generation sequencing informatics pipelines
Amy S. Gargis,Lisa V. Kalman,David P. Bick,Cristina da Silva,David Dimmock,Birgit Funke,Birgit Funke,Sivakumar Gowrisankar,Sivakumar Gowrisankar,Sivakumar Gowrisankar,Madhuri Hegde,Shashikant Kulkarni,Christopher E. Mason,Rakesh Nagarajan,Karl V. Voelkerding,Karl V. Voelkerding,Elizabeth A. Worthey,Nazneen Aziz,Nazneen Aziz,John Barnes,Sarah F. Bennett,Himani Bisht,Deanna M. Church,Deanna M. Church,Zoya Dimitrova,Shaw R. Gargis,Nabil Hafez,Tina Hambuch,Fiona Hyland,Ruth Ann Luna,Duncan MacCannell,Tobias Mann,Tobias Mann,Megan R. McCluskey,Timothy K. McDaniel,Lilia Ganova-Raeva,Heidi L. Rehm,Heidi L. Rehm,Jeffrey Reid,Jeffrey Reid,David S. Campo,Richard B. Resnick,Perry G. Ridge,Perry G. Ridge,Marc L. Salit,Pavel Skums,Lee-Jun C. Wong,Barbara A. Zehnbauer,Justin M. Zook,Ira M. Lubin +49 more
TL;DR: This research highlights the need to understand more fully the role of Epstein-Barr virus in the development and management of central nervous system disorders.
Journal ArticleDOI
Assuring the Quality of Next-Generation Sequencing in Clinical Microbiology and Public Health Laboratories
TL;DR: This review highlights currently available standards and guidelines for the implementation of NGS in the clinical and public health laboratory setting, and it includes considerations for NGS test validation, quality control procedures, proficiency testing, and reference materials.
Journal ArticleDOI
Rapid Detection of Genetic Engineering, Structural Variation, and Antimicrobial Resistance Markers in Bacterial Biothreat Pathogens by Nanopore Sequencing.
TL;DR: In this paper, a nanopore sequencer was used for whole-genome sequencing of Bacillus anthracis (anthrax) and Yersinia pestis (plague) during a biothreat emergency.
Journal ArticleDOI
Zif, the zoocin A immunity factor, is a FemABX-like immunity protein with a novel mode of action.
Shaw R. Gargis,Amy S. Gargis,Harry E. Heath,Lucie S. Heath,Paul A. LeBlanc,Maria M. Senn,Brigitte Berger-Bächi,Robin S. Simmonds,Gary L. Sloan +8 more
TL;DR: Zif is a novel FemABX-like immunity factor because it provides resistance to a bacteriolytic endopeptidase by lengthening the peptidoglycan cross bridge rather than by causing an amino acid substitution.